Search
  • HPR

Accelerating the Development of a Malaria Vaccine

The research collaboration project, “Transmission-blocking Vaccine of Malaria” has been accepted by the Global Health Innovative Technology Fund’s product development program. Hamamatsu Pharma Research continues to challenge this new therapeutic field through a collaboration with University of Florida.


https://www.ghitfund.org/newsroom/press/detail/197/





0 views

Follow us:

HPR's AAALAC
HPR ProudCROMember_Biocom

Copyright © HAMAMATSU PHARMA RESEARCH U.S.A., Inc All rights reserved.

Hamamatsu Pharma Research U.S.A., Inc

3070 Bristol Street, Suite 400 Costa Mesa, CA 92626

E-mail: info_us@hpharma.jp